Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1982
Correlation between the disposition of [14C]clofilium and its cardiac electrophysiological effectT D Lindstrom, P J Murphy, J K Smallwood, et al.Toxicology and Applied Pharmacology|January 1, 1986
Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogsM I Steinberg, J K Smallwood, D R Holland, et al.Diabetes|May 20, 1999
Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetesF E Yakubu-Madus, W T Johnson, K M Zimmerman, et al.Journal of Cardiovascular Pharmacology|July 1, 1981
Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibersM I Steinberg, M E Sullivan, S A Wiest, et al.Life Sciences|January 1, 1991
Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteriesR F Kauffman, J S Bean, K M Zimmerman, et al.European Journal of Pharmacology|October 2, 1990
Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brainD R Gehlert, S L Gackenheimer, J K Reel, et al.Journal of Medicinal Chemistry|July 1, 1988
Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogueD W Robertson, E E Beedle, H Wilson, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureasM I Steinberg, S A Wiest, K M Zimmerman, et al.Journal of Medicinal Chemistry|January 1, 1990
Atrial natriuretic peptide receptor modulators: effects of disubstituted quinazolines on receptor binding and in vitro biological activityM J Yu, J R McCowan, M I Steinberg, et al.Journal of Cardiovascular Pharmacology|September 1, 1989
LY249933: a cardioselective 1,4-dihydropyridine with positive inotropic activityD R Holland, J H Wikel, R F Kauffman, et al.Pageof 4